Pre-Market Movers: Genenta, HCWC, Zhongchao Lead Gains

Genenta Science (GNTA), HCWC, and Zhongchao (ZCMD) surged in pre-market trading on Monday, June 1, 2026, leading advancing stocks. Genenta gained after positive interim data from a Phase 2 glioblastoma trial, while HCWC climbed on a $120 million acquisition of a regional healthcare staffing firm. Zhongchao advanced on better-than-expected first-quarter revenue guidance. Genenta shares rose 18% to $4.50, HCWC added 12% to $8.10, and ZCMD jumped 9% to $2.30. The moves defied a flat broader market, with S&P 500 futures down 0.1%. All three companies have drawn retail interest in recent weeks, contributing to elevated pre-market volume.